50.34 USD
↘ 0.31 (0.61%)LIVE (AS OF 10:02 AM EST)
Travere Therapeutics, Inc. Common Stock (TVTX) trades at $50.34 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, TVTX trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 13, 2026.